India Looks To Model New Central Drug Authority After U.S. FDA
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - With elections to parliament slated for next year, India's Congress Party-led government is expected to soon pass a slew of bills in the pharmaceutical sector, including that for a central drug authority